A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer

BACKGROUND: Event-free survival (EFS) has been listed on the FDA Table of Surrogate Endpoints as a surrogate measure that can be considered for accelerated or traditional approval in breast cancer. However, no studies have evaluated the correlation between the treatment effects on EFS and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyawali, Bishal, D'Andrea, Elvira, Franklin, Jessica M., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910654/
https://www.ncbi.nlm.nih.gov/pubmed/33681740
http://dx.doi.org/10.1016/j.eclinm.2021.100730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910654/
https://www.ncbi.nlm.nih.gov/pubmed/33681740
http://dx.doi.org/10.1016/j.eclinm.2021.100730

Ejemplares similares